FR2583770B1 - EXPRESSION OF HUMAN IL-2 IN MAMMALIAN CELLS BY A RECOMBINANT POXVIRUS - Google Patents

EXPRESSION OF HUMAN IL-2 IN MAMMALIAN CELLS BY A RECOMBINANT POXVIRUS

Info

Publication number
FR2583770B1
FR2583770B1 FR8509480A FR8509480A FR2583770B1 FR 2583770 B1 FR2583770 B1 FR 2583770B1 FR 8509480 A FR8509480 A FR 8509480A FR 8509480 A FR8509480 A FR 8509480A FR 2583770 B1 FR2583770 B1 FR 2583770B1
Authority
FR
France
Prior art keywords
expression
human
mammalian cells
recombinant poxvirus
poxvirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8509480A
Other languages
French (fr)
Other versions
FR2583770A1 (en
Inventor
Marie-Paule Kieny
Paul Sondermeyer
Jean-Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR8509480A priority Critical patent/FR2583770B1/en
Priority to JP61503357A priority patent/JPS63500005A/en
Priority to EP86401349A priority patent/EP0206939A1/en
Priority to PCT/FR1986/000213 priority patent/WO1986007610A1/en
Priority to ZA864561A priority patent/ZA864561B/en
Priority to AU59676/86A priority patent/AU5967686A/en
Publication of FR2583770A1 publication Critical patent/FR2583770A1/en
Priority to DK087887A priority patent/DK87887D0/en
Application granted granted Critical
Publication of FR2583770B1 publication Critical patent/FR2583770B1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8509480A 1985-06-21 1985-06-21 EXPRESSION OF HUMAN IL-2 IN MAMMALIAN CELLS BY A RECOMBINANT POXVIRUS Expired FR2583770B1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR8509480A FR2583770B1 (en) 1985-06-21 1985-06-21 EXPRESSION OF HUMAN IL-2 IN MAMMALIAN CELLS BY A RECOMBINANT POXVIRUS
JP61503357A JPS63500005A (en) 1985-06-21 1986-06-19 Expression of human IL-2 in mammalian cells by recombinant poxviruses
EP86401349A EP0206939A1 (en) 1985-06-21 1986-06-19 Expression of human IL-2 in mammalian cells by a recombined pox virus
PCT/FR1986/000213 WO1986007610A1 (en) 1985-06-21 1986-06-19 Expression of human il-2 in mammal cells by means of a recombined poxvirus
ZA864561A ZA864561B (en) 1985-06-21 1986-06-19 Expression of human il-2 in mammalian cells by a recombinant poxvirus
AU59676/86A AU5967686A (en) 1985-06-21 1986-06-19 Expression of human il-2 in mammal cells by means of a recombined poxvirus
DK087887A DK87887D0 (en) 1985-06-21 1987-02-20 EXPRESSION OF HUMANT IL-2 IN PATTERN CELLS BY A RECOMBINANT POXVIRUS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8509480A FR2583770B1 (en) 1985-06-21 1985-06-21 EXPRESSION OF HUMAN IL-2 IN MAMMALIAN CELLS BY A RECOMBINANT POXVIRUS

Publications (2)

Publication Number Publication Date
FR2583770A1 FR2583770A1 (en) 1986-12-26
FR2583770B1 true FR2583770B1 (en) 1988-08-19

Family

ID=9320527

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8509480A Expired FR2583770B1 (en) 1985-06-21 1985-06-21 EXPRESSION OF HUMAN IL-2 IN MAMMALIAN CELLS BY A RECOMBINANT POXVIRUS

Country Status (7)

Country Link
EP (1) EP0206939A1 (en)
JP (1) JPS63500005A (en)
AU (1) AU5967686A (en)
DK (1) DK87887D0 (en)
FR (1) FR2583770B1 (en)
WO (1) WO1986007610A1 (en)
ZA (1) ZA864561B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells
CA1339346C (en) * 1986-08-01 1997-08-26 Ian Allister Ramshaw Recombinant chimeric vaccine
US7238673B2 (en) 1989-03-31 2007-07-03 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
JPH02148450U (en) * 1989-05-18 1990-12-17
JPH02148452U (en) * 1989-05-18 1990-12-17
JPH02148451U (en) * 1989-05-18 1990-12-17
US6652850B1 (en) 1993-09-13 2003-11-25 Aventis Pharmaceuticals Inc. Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
US5834441A (en) * 1993-09-13 1998-11-10 Rhone-Poulenc Rorer Pharmaceuticals Inc. Adeno-associated viral (AAV) liposomes and methods related thereto
FR2710536B1 (en) * 1993-09-29 1995-12-22 Transgene Sa Anti-cancer use of a viral vector comprising a gene which modulates the immune and / or inflammatory response.
US6344445B1 (en) 1995-10-19 2002-02-05 Cantab Pharmaceutical Research Limited Herpes virus vectors and their uses
FR2766091A1 (en) 1997-07-18 1999-01-22 Transgene Sa ANTITUMOR COMPOSITION BASED ON MODIFIED IMMUNOGENIC POLYPEPTIDE WITH CELL LOCATION
JP4634710B2 (en) * 2002-07-31 2011-02-16 ゲネルクス コーポレーション Microorganisms and cells for tumor diagnosis and treatment
WO2013083254A1 (en) 2011-12-09 2013-06-13 Bavarian Nordic A/S Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
JPH0795954B2 (en) * 1982-11-30 1995-10-18 アメリカ合衆国 Method for producing recombinant poxvirus for expression of foreign gene

Also Published As

Publication number Publication date
WO1986007610A1 (en) 1986-12-31
JPS63500005A (en) 1988-01-07
AU5967686A (en) 1987-01-13
ZA864561B (en) 1987-03-25
EP0206939A1 (en) 1986-12-30
DK87887A (en) 1987-02-20
FR2583770A1 (en) 1986-12-26
DK87887D0 (en) 1987-02-20

Similar Documents

Publication Publication Date Title
FR2583770B1 (en) EXPRESSION OF HUMAN IL-2 IN MAMMALIAN CELLS BY A RECOMBINANT POXVIRUS
AU3393993A (en) Method of administering proteins to living skin cells
DK478786D0 (en) CYSTEIN-DEFINED MUTEINS OF BIOLOGICALLY ACTIVE HUMAN TUMOR NECROCESS FACTOR PROTEINS
ZA896468B (en) Lyophilization of red blood cells
BR8603431A (en) DENTAL PROSTHESIS
AU3212689A (en) Medical material permitting cells to enter thereinto and artificial skin
IT1213915B (en) ANTI-SOLAR COSMETIC PREPARATION FOR FACE AND BODY
MC1821A1 (en) PRONOUNCED EXPRESSION OF INTERLEUKIN-2-HUMAN IN MAMMALIAN CELLS
IT1206292B (en) DURABLE ELECTRODES FOR ELECTROLYSIS AND PROCEDURE TO PRODUCE THEM
FR2581310B1 (en) THERAPEUTIC COMPOSITION COMPRISING A-LINOLENIC ACID AND A COMPOUND CAPABLE OF PROMOTING ACID THROUGH THE CELL MEMBRANE AND PLANT EXTRACT COMPRISING THE ACID AND THE COMPOUND
AT388667B (en) DENTAL CARE
IL80302A0 (en) Biologically active derivatives of human epsilon-interferon
IT1190264B (en) PREPARED FOR THE CONTROL OF DENTAL PLATE AND CARIES
IT1201429B (en) PROCEDURE TO OBTAIN HUMAN ALPH-2 LEFOCONARY INTERFERON
AU3212589A (en) Medical material permitting cells to enter thereinto and artificial skin
IT8647912A0 (en) ENZYMATIC PROCEDURE TO PREPARE SULFUR-CONTAINING AMINO ACIDS
FR2628323B1 (en) NEW THERAPEUTIC USE OF INTERLEUKIN-6
FR2580175B1 (en) NEW THERAPEUTIC USE OF HUMAN UROGASTRONE
FR2616587B1 (en) SOURCE OF IONS WITH FOUR ELECTRODES
EE03170B1 (en) Stimulation of cytotoxic activity of peripheral blood mononuclear cells by IL-10
IT1213463B (en) ESPECIALLY FOR CONTACT LENSES AND HYDROPHILIC COPOLYMER SUITABLE FOR MEDICAL PURPOSES AND METHOD TO PREPARE IT
FR2651005B1 (en) ROWS OF CELLS INFECTABLE BY A RETROVIRUS AND CONTAINING AN ACTIVABLE MARKER ON THE OCCASION OF THE INFECTION
FR2584922B1 (en) HUMAN BODY ELONGATION TABLE
KR900019561A (en) Colony stimulating factor of human granular white blood cells
FR2541579B1 (en) INTERFERON N HUMAN LEUCOCYTAIRE AND METHOD FOR OBTAINING SAME IN BACTERIAL CELLS

Legal Events

Date Code Title Description
ST Notification of lapse